Prime Minister Narendra Modi on Monday interacted virtually with representatives of three pharmaceutical companies involved in developing a Covid-19 vaccine.
Modi interacted with scientists of the Gennova Biopharmaceuticals Limited of Pune and Biological E Limited and Dr. Reddy’s Laboratories Limited of Hyderabad during the virtual meeting, a report stated.
Modi appreciated the efforts of these scientists in developing a Covid-19 vaccine and discussed the potential of various platforms for vaccine development.
He also asked the companies to give their suggestions regarding the regulatory processes involved in vaccine production and related matters.
Modi also directed the scientists to make efforts to sensitize the general public about the vaccine, its efficacy and other vital matters related to it.
Also read: Prime Minister Narendra Modi to Launch Jan Andolan for COVID-19 Appropriate Behaviour today
With the Covid-19 pandemic affecting millions across the globe, scientists are now racing against time to develop a vaccine.
The meeting also focused on several issues related to the vaccine delivery process such as its logistics, transport, cold chain, etc.
The vaccines that are being developed by these companies are at different stages of trials and detailed information and results will be available early next year.
The PM also asked all government departments concerned to assist these manufactures in resolving various issues related to vaccine production and delivery so as to fulfill the needs of the country and the entire world.
Modi had recently visited three pharmaceutical companies -Zydus Biotech Park in Ahmedabad, Bharat Biotech in Hyderabad and Serum Institute of India (SII)in Pune- involved in the manufacture of the Covid-19 vaccine.
He took stock of their vaccine production process.
Meanwhile, SII had also announced that the company is in the process of applying for emergency use authorization for its Covid-19 vaccine.
The Union health minister, Harsh Vardhan had also said that vaccines manufactured and trialed in the country will be rolled out for use within the next few months.